Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mologen

Mologen
PUBLIC STATUS
41-50 EMPLOYEES
MGNK STOCK SYMBOL
$3.29 SHARE PRICE (As of Monday Closing)
Description

Mologen AG is a Germany based biotechnology company. It is principally engaged in the research, development, and marketing of products in the area of molecular medicine. The company's primary focus is on oncology and severe infectious diseases. The focus of the research is the dSLIM technologies, which facilitate the use of DNA as a drug for diseases that were previously untreatable. The product pipeline of the organization includes Lefitolimod and EnanDIM.

Website
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
BER
Primary Office
  • Fabeckstraße 30
  • 14195 Berlin
  • Germany

+49 030 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mologen’s full profile, request a free trial.

Mologen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.54 - $8.22 $39.7M $3.25 -$1.46 12.1M

Mologen Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 17,274 14,269 81,071 4,093
Revenue 3,596 3,596 53 82
EBITDA (13,290) (13,290) (21,042) (22,761)
Net Income (14,023) (14,023) (21,744) (23,232)
Total Assets 10,704 10,704 9,724 22,466
Total Debt 6,365 6,365 6,512 2,232
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mologen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mologen‘s full profile, request access.

Request full access to PitchBook

Mologen Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Mologen‘s full profile, request access.

Request full access to PitchBook

Mologen Executive Team (5)

Name Title Board
Seat
Contact
Info
Ignacio Faus Ph.D Chief Executive Officer
Walter Miller Chief Financial Officer & Board Member
Burghardt Wittig Ph.D Co-Founder
Matthias Baumann Chief Medical Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Mologen Board Members (6)

Name Representing Role Since Contact
Info
Mariola Söhngen Ph.D Mologen Board Member 000 0000
Oliver Krautscheid Self Board Member 000 0000
Stefan Manth Ph.D Mologen Non-Executive Director & Deputy Chairman, Scientific Advisory Board Member 000 0000
Susanne Klimek Self Board Member 000 0000
Walter Miller Mologen Chief Financial Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »